Clinical Trials Update: Sept. 5, 2006
Non-Hodgkin's Lymphoma Bipolar Disorders Alzheimer's Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This trial will evaluate a single-agent chemotherapy treatment for people with aggressive non-Hodgkin's lymphoma who have received two or more chemotherapy regimens. Volunteers with histologically-confirmed aggressive [de novo or transformed] NHL according to REAL/WHO classification may be eligible. The histological specimen used to determine eligibility must be the most recently obtained specimen. Other criteria apply.
The research sites are located worldwide.
This research study will test the effects of an investigational medication for bipolar disorder. Candidates at least 18 who have had a manic or mixed episode within the last three months may qualify. Participants will receive study-related medical care, laboratory work, and evaluations at no cost.
The research site is in Lexington, Ky.
This trial will study the effectiveness and safety of donepezil hydrochloride (Aricept) in the Hispanic population. Hispanic volunteers age 50 and older who have been diagnosed with Alzheimer's disease and who do not have hypersensitivity to a cholinesterase inhibitor may be eligible.
The research site is in Tampa, Fla.
Copyright 2006 Thomson CenterWatch. All rights reserved.